• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞贫血中的组织因子和凝血酶。

Tissue factor and thrombin in sickle cell anemia.

机构信息

Department of Medicine, Division of Hematology and Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

出版信息

Thromb Res. 2012 May;129 Suppl 2(Suppl 2):S70-2. doi: 10.1016/j.thromres.2012.02.038. Epub 2012 Mar 6.

DOI:10.1016/j.thromres.2012.02.038
PMID:22398014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3335974/
Abstract

Sickle cell anemia is an inherited hematologic disorder associated with hemolytic and vaso-occlusive complications. An activation of coagulation is also a prominent feature of sickle cell anemia. Growing evidence indicates that coagulation may contribute to the inflammation and vascular injury in sickle cell anemia. This review focuses on tissue factor expression and its contribution to the activation of coagulation, thrombosis and vascular inflammation in sickle cell anemia.

摘要

镰状细胞贫血是一种遗传性血液疾病,与溶血性和血管阻塞性并发症有关。凝血的激活也是镰状细胞贫血的一个显著特征。越来越多的证据表明,凝血可能导致镰状细胞贫血中的炎症和血管损伤。本文综述了组织因子表达及其在镰状细胞贫血中凝血激活、血栓形成和血管炎症中的作用。

相似文献

1
Tissue factor and thrombin in sickle cell anemia.镰状细胞贫血中的组织因子和凝血酶。
Thromb Res. 2012 May;129 Suppl 2(Suppl 2):S70-2. doi: 10.1016/j.thromres.2012.02.038. Epub 2012 Mar 6.
2
Prothrombotic aspects of sickle cell disease.镰状细胞病的促血栓形成方面。
J Thromb Haemost. 2017 Jul;15(7):1307-1316. doi: 10.1111/jth.13717.
3
Interplay between coagulation and vascular inflammation in sickle cell disease.镰状细胞病中凝血与血管炎症的相互作用。
Br J Haematol. 2013 Jul;162(1):3-14. doi: 10.1111/bjh.12336. Epub 2013 Apr 18.
4
Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.血浆因子VII和凝血酶 - 抗凝血酶III水平表明镰状细胞病患者的组织因子活性增加。
Br J Haematol. 1992 Aug;81(4):539-44. doi: 10.1111/j.1365-2141.1992.tb02989.x.
5
Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease.在镰状细胞病小鼠模型中,组织因子对炎症和心脏肥大的凝血酶非依赖性作用。
Blood. 2016 Mar 10;127(10):1371-3. doi: 10.1182/blood-2015-11-681114. Epub 2016 Jan 27.
6
Association of coagulation activation with clinical complications in sickle cell disease.凝血激活与镰状细胞病临床并发症的关系。
PLoS One. 2012;7(1):e29786. doi: 10.1371/journal.pone.0029786. Epub 2012 Jan 11.
7
Excess of heme induces tissue factor-dependent activation of coagulation in mice.血红素过量会诱导小鼠体内组织因子依赖性凝血激活。
Haematologica. 2015 Mar;100(3):308-14. doi: 10.3324/haematol.2014.114728. Epub 2015 Jan 16.
8
Role of the coagulation system in the pathogenesis of sickle cell disease.凝血系统在镰状细胞病发病机制中的作用。
Blood Adv. 2019 Oct 22;3(20):3170-3180. doi: 10.1182/bloodadvances.2019000193.
9
Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease.FXa 和凝血酶在镰状细胞病小鼠模型中对血管炎症的差异贡献。
Blood. 2014 Mar 13;123(11):1747-56. doi: 10.1182/blood-2013-08-523936. Epub 2014 Jan 21.
10
Biased agonism of protease-activated receptor-1 regulates thromboinflammation in murine sickle cell disease.蛋白酶激活受体-1 的偏性激动调节小鼠镰状细胞病中的血栓炎症。
Blood Adv. 2024 Jun 25;8(12):3272-3283. doi: 10.1182/bloodadvances.2023011907.

引用本文的文献

1
COVID-19 and Sickle Cell Disease: Two Independent Risk Factors for Venous Thromboembolism.新型冠状病毒肺炎与镰状细胞病:静脉血栓栓塞的两个独立危险因素。
Cureus. 2023 Apr 6;15(4):e37226. doi: 10.7759/cureus.37226. eCollection 2023 Apr.
2
The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease.镰状细胞病治疗中不断演变的药物治疗格局。
Mediterr J Hematol Infect Dis. 2020 Jan 1;12(1):e2020010. doi: 10.4084/MJHID.2020.010. eCollection 2020.
3
Rheumatoid Arthritis in Sickle-Cell Population: Pathophysiologic Insights, Clinical Evaluation and Management.镰状细胞人群中的类风湿性关节炎:病理生理见解、临床评估与管理
Rheumatology (Sunnyvale). 2017;7(3). doi: 10.4172/2161-1149.1000225. Epub 2017 Sep 12.
4
Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach.内皮素受体拮抗剂在镰状细胞病中的应用:一种有前景的新治疗方法。
Life Sci. 2016 Aug 15;159:15-19. doi: 10.1016/j.lfs.2016.04.001. Epub 2016 Apr 3.
5
Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies.镰状细胞病中的血管闭塞:病理生理学和新型靶向治疗。
Blood. 2013 Dec 5;122(24):3892-8. doi: 10.1182/blood-2013-05-498311. Epub 2013 Sep 19.

本文引用的文献

1
Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.凝血酶生成揭示镰状细胞病儿童血浆中存在高促凝潜能。
Am J Hematol. 2012 Feb;87(2):145-9. doi: 10.1002/ajh.22206. Epub 2011 Nov 4.
2
A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction.一项关于辛伐他汀在镰状细胞病中的短期应用的初步研究:对血管功能障碍标志物的影响。
Br J Haematol. 2011 Jun;153(5):655-63. doi: 10.1111/j.1365-2141.2010.08480.x. Epub 2011 Apr 8.
3
Thrombosis and sickle cell disease.血栓与镰状细胞病。
Semin Thromb Hemost. 2011 Apr;37(3):226-36. doi: 10.1055/s-0031-1273087. Epub 2011 Mar 31.
4
Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S.表达血红蛋白-S 的小鼠脑微血管中血栓形成增强的机制。
Blood. 2011 Apr 14;117(15):4125-33. doi: 10.1182/blood-2010-08-301366. Epub 2011 Feb 8.
5
Sickle-cell disease.镰状细胞病。
Lancet. 2010 Dec 11;376(9757):2018-31. doi: 10.1016/S0140-6736(10)61029-X. Epub 2010 Dec 3.
6
P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease.P 选择素介导的血小板-中性粒细胞聚集体形成激活了小鼠和人类镰状细胞病中的中性粒细胞。
Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2392-9. doi: 10.1161/ATVBAHA.110.211615. Epub 2010 Nov 11.
7
Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease.核因子-κB(NF-κB)成分 p50 在血单核细胞中调节镰状转(transgenic)基因小鼠内皮细胞组织因子的表达:对镰状细胞病凝血功能障碍的影响。
Transl Res. 2010 Apr;155(4):170-7. doi: 10.1016/j.trsl.2009.10.004. Epub 2009 Nov 11.
8
The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice.组蛋白去乙酰化酶抑制剂曲古抑菌素 A 和丁酸钠在镰状细胞转基因小鼠的血管病理生物学中具有多种获益方式。
Blood. 2010 Mar 25;115(12):2483-90. doi: 10.1182/blood-2009-02-204990. Epub 2010 Jan 6.
9
Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in vivo in the sickle transgenic mouse.内皮型一氧化氮合酶和一氧化氮调节活体镰状转基因小鼠内皮组织因子的表达。
Am J Hematol. 2010 Jan;85(1):41-5. doi: 10.1002/ajh.21582.
10
Hypercoagulability and thrombotic complications in hemolytic anemias.溶血性贫血中的高凝状态和血栓并发症。
Haematologica. 2009 Nov;94(11):1481-4. doi: 10.3324/haematol.2009.013672.